DIMITRIOS KYPARISSOPOULOS

MD, MD ph, FRCS ea

THORACIC SURGEON

RFA (Radio Frequency Ablation) surgery for cancer metastases in the lung for the first time in Cyprus - by Thoracic Surgeont Dr. Dimitrios Kyparissopoulos

The first RFA (Radio Frequency Ablation) session in Cyprus, for cancer metastases in the lung took place in the Mediterranean Hospital of Cyprus with great success.

It is an innovative surgical method with the use of multislice CT and with the participation of leading scientists from the Royal Brompton and Hearfield Hospital NHS Foundation London Trust.

The operation was performed on a 22-year old patient, Saturday 14/05/16, in the Mediterranean Hospital of Cyprus, by the thoracic team of Dr. Dimitrios Kyparissopoulos.

The surgery was painless, took about 2.5 hours and the patient remained three days in the hospital in order to receive the corresponding medication.

Dr. Kyparissopoulos pointed out that the operation was performed successfully, and added that the RFA surgery can be performed at all ages, for cancer metastases in the lung.

Source (greek):  

Purpose: Percutaneous image guided radiofrequency ablation (RFA) is increasingly used as an alternative treatment option for patients with inoperable primary lung cancer (NSCLC) but there are little published outcome data. We report safety & efficacy of RFA in patients with NSCLC (stages 1-4) at 1 & 2 years.

Methods and Materials: Under general anaesthesia 38 patients, underwent RFA of 50 pulmonary tumours. Survival were evaluated prospectively at 3, 6, 9,12 & 24 months whilst complications was assessed 1 month post procedure.

Results: There were no cases of procedure related mortality. Complications included pneumothorax requiring intercostal drain (ICD) insertion (n=20, 53%), small pneumothorax not requiring ICD (n=3, 8%) and pleural effusion (n=2, 5%). One year overall survival and cancer specific (C/S) for tumours classified as Stage 1 (n=20) were 100% and 100% respectively. Stage 2 (n=7) 85% & 100% respectively and stage 4 (n=11) 64% & 73% respectively. Two year survivals (overall & C/S) for Stage 1 were 85% & 95%, in Stage 2 patients 43% & 86% and those at Stage 4 45% & 64% respectively.

Conclusion: RFA is a safe, effective and well-tolerated treatment option in patients with inoperable lung cancer. Our study also shows that ablation therapy may be useful in higher stage tumours.

 

Julia Beeson, Vladimir Anikin, Sundeep Kaul, Dimitrios Kyparissopoulos, Paras Dalal
Department of Thoracic Surgery and Radiology, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom

 

Published by 

Volos city, Greece, shakes the ground by breaking the record of cancer mortality whereas in London, according to Harefield’s Hospital Thoracic Surgeon Dimitrios Kyparissopoulos, early stage cancer is almost 100% curable!

Cancer casualties toll in Magnesia increases: Have we lost the battle or is something else occurring?